BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
BOSTON SCIENTIFIC CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$45.05+0.66 (+1.49%)
Close on Oct 19, 2026
- Market cap
- $66.44B
- P/E (TTM)
- 18.2
- Dividend yield
- –
Boston Scientific statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Boston Scientific | Industry median |
|---|---|---|
| Market Cap | $65.29B | $230.55M |
| Enterprise Value | $77.61B | $202.97M |
| PE Ratio | 18.24 | 31.60 |
| PS Ratio | 3.11 | 3.10 |
| PB Ratio | 2.62 | 3.04 |
| P/FCF Ratio | 18.01 | 27.30 |
| P/OCF Ratio | 14.42 | 22.47 |
Enterprise value
| Measure | Boston Scientific | Industry median |
|---|---|---|
| EV / Sales | 3.70 | 2.91 |
| EV / EBITDA | 13.95 | 19.74 |
| EV / EBIT | 18.69 | 24.80 |
| EV / FCF | 21.41 | 27.89 |
Income (trailing twelve months)
| Measure | Boston Scientific | Industry median |
|---|---|---|
| Revenue | $21.00B | $102.39M |
| Gross Profit | $14.68B | $60.36M |
| Operating Income | $4.15B | -$4.31M |
| Pretax Income | $3.86B | -$2.37M |
| EBITDA | $5.57B | -$1.98M |
| EPS (Diluted) | $2.47 | -$0.08 |
Margins
| Measure | Boston Scientific | Industry median |
|---|---|---|
| Gross Margin | 69.9% | 55.2% |
| Operating Margin | 19.8% | -6.04% |
| Pretax Margin | 18.4% | -4.11% |
| EBITDA Margin | 26.5% | -2.67% |
| FCF Margin | 17.3% | 0.02% |
Returns
| Measure | Boston Scientific | Industry median |
|---|---|---|
| Return on Invested Capital (ROIC) | 11.2% | -3.69% |
| Return on Capital Employed (ROCE) | 10.7% | -9.07% |
Growth
| Measure | Boston Scientific | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 13.5% | 8.85% |
| EPS Growth (YoY) | 47.0% | 10.6% |
| FCF Growth (YoY) | 4.02% | 9.68% |
| Revenue Growth (3Y CAGR) | 16.5% | 7.08% |
| Revenue Growth (5Y CAGR) | 15.2% | 11.8% |
| EPS Growth (3Y CAGR) | 62.8% | 3.11% |
Balance sheet
| Measure | Boston Scientific | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $539.00M | $36.66M |
| Total Debt | $12.62B | $97.65M |
| Net Cash (Debt) | -$12.09B | $3.92M |
| Net Cash Per Share | -$8.34 | $0.28 |
| Equity (Book Value) | $24.93B | $55.33M |
| Book Value Per Share | $17.20 | $2.87 |
| Tangible Book Value | -$628.00M | $10.79M |
| Working Capital | $1.54B | $56.72M |
Financial position
| Measure | Boston Scientific | Industry median |
|---|---|---|
| Current Ratio | 1.24 | 2.48 |
| Quick Ratio | 0.08 | 1.53 |
| Debt / Equity | 0.51 | 0.41 |
| Debt / EBITDA | 2.27 | 2.40 |
| Debt / FCF | 3.48 | 3.49 |
| Net Debt / EBITDA | 2.17 | 1.53 |
| Interest Coverage | 11.44 | -1.85 |
Cash flow (trailing twelve months)
| Measure | Boston Scientific | Industry median |
|---|---|---|
| Operating Cash Flow | $4.53B | -$566.22K |
| Capital Expenditures | -$904.00M | -$3.69M |
| Free Cash Flow | $3.63B | -$696.00K |
| FCF Per Share | $2.50 | -$0.02 |
Efficiency
| Measure | Boston Scientific | Industry median |
|---|---|---|
| Asset Turnover | 0.48 | 0.58 |
| Inventory Turnover | 2.07 | 2.21 |
| Revenue Per Employee | $355.86K | $322.92K |
| Employee Count | 59,000 | 185 |
Dividends and yields
| Measure | Boston Scientific | Industry median |
|---|---|---|
| FCF Yield | 5.55% | -0.45% |
Shares
| Measure | Boston Scientific | Industry median |
|---|---|---|
| Shares Outstanding | 1,449,230,000 | 44,302,700 |
| Shares Change (YoY) | -0.05% | 3.36% |
| Float | 1,446,550,000 | 37,462,700 |
| Shares Held by Insiders | 0.19% | 10.5% |
| Shares Held by Institutions | 92.1% | 63.5% |
Taxes
| Measure | Boston Scientific | Industry median |
|---|---|---|
| Income Tax | $192.00M | $1.52M |
| Effective Tax Rate | 4.97% | 18.5% |
Scores
| Measure | Boston Scientific | Industry median |
|---|---|---|
| Graham Number | $30.92 | $35.97 |
| Graham Upside | -31.4% | -57.0% |
| Altman Z-Score | 3.00 | 1.95 |
Calculated by StockData from Boston Scientific's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.